Search Results - "TIBBITTS, J"

Refine Results
  1. 1
  2. 2

    Semi-mechanistic Population Pharmacokinetic Model of Multivalent Trastuzumab Emtansine in Patients with Metastatic Breast Cancer by Chudasama, V L, Schaedeli Stark, F, Harrold, J M, Tibbitts, J, Girish, S R, Gupta, M, Frey, N, Mager, D E

    Published in Clinical pharmacology and therapeutics (01-10-2012)
    “…Trastuzumab emtansine (T‐DM1) is an antibody–drug conjugate (ADC) composed of multiple molecules of the antimicrotubule agent DM1 linked to trastuzumab, a…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Vulnerability of mouse cortical neurons to doxorubicin-induced apoptosis is strain-dependent and is correlated with mRNAs encoding Fas, Fas-Ligand, and metalloproteinases by Wetzel, M, Tibbitts, J, Rosenberg, G A, Cunningham, L A

    Published in Apoptosis (London) (01-09-2004)
    “…Cell surface death receptor-mediated neuronal apoptosis, which is a critical component of neurodegeneration, is modulated by matrix metalloproteinases (MMPs)…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Sterilizing immunity against experimental Helicobacter pylori infection is challenge-strain dependent by Kleanthous, Harry, Tibbitts, Timothy J, Gray, Heather L, Myers, Gwendolyn A, Lee, Cynthia K, Ermak, Thomas H, Monath, Thomas P

    Published in Vaccine (14-09-2001)
    “…The development of a murine model of Helicobacter pylori infection through serial in vivo passage of candidate strains has enabled a quantitative assessment of…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Risk of Helicobacter pylori infection among long-term residents in developing countries by Becker, S I, Smalligan, R D, Frame, J D, Kleanthous, H, Tibbitts, T J, Monath, T P, Hyams, K C

    “…The seroprevalence and incidence of Helicobacter pylori infection were determined among 312 North American missionaries who were serving in developing…”
    Get more information
    Journal Article
  11. 11

    P016 SZN-1326, a Wnt signal activator, is more efficacious than cyclosporine A in an acute DSS model by Xie, L, Baribault, H, Lu, C, Handa, P, Newman, M, Le, L, Liu, A, Mutha, D, Deshmukh, S, Shah, D, Tun, C, Le, T, Fletcher, R, Chen, H, Ye, J, Tibbitts, J, Srinivasan, U, Li, Y, Vanhove, G, Yeh, W C

    Published in Journal of Crohn's and colitis (27-05-2021)
    “…Abstract Background Current Inflammatory bowel disease (IBD) treatments focus on inhibition of excessive inflammation, and clinical remission rates have…”
    Get full text
    Journal Article
  12. 12

    P023 SZN-1326, a Wnt agonist, improved epithelial healing and ameliorated colitis in a chronic DSS model, in stark contrast to anti-TNF and anti-IL-12/23p40 antibodies by Xie, L, Handa, P, Tun, C, Liu, A, Lu, C, Baribault, H, Newman, M, Le, L, Shah, D, Deshmukh, S, Mutha, D, Le, T, Fletcher, R, Chen, H, Ye, J, Tibbitts, J, Srinivasan, U, Li, Y, Vanhove, G, Yeh, W C

    Published in Journal of Crohn's and colitis (27-05-2021)
    “…Abstract Background All currently approved treatments for Inflammatory bowel disease (IBD) and the majority of drugs in the pipeline are anti-inflammatory…”
    Get full text
    Journal Article
  13. 13

    Issues related to the use of canines in toxicologic pathology: Issues with pharmacokinetics and metabolism by TIBBITTS, Jay

    Published in Toxicologic pathology (01-01-2003)
    “…The dog is a commonly used animal model by virtue of its size, well-characterized physiology, and ease of handling. For these reasons and others, dogs are also…”
    Get full text
    Conference Proceeding Journal Article
  14. 14
  15. 15

    A phase I study of weekly dosing of trastuzumab-DM1 (T-DM1) in patients with advanced HER2+ breast cancer by Krop, IE, Mita, M, Burris, HA, Birkner, M, Girish, S, Tibbitts, J, Holden, SN, Lutzker, SG, Modi, S

    Published in Cancer research (Chicago, Ill.) (15-01-2009)
    “…Abstract Abstract #3136 Background: T-DM1, a novel HER2 antibody-drug conjugate (ADC) in development for HER2+ breast cancer (BC), combines activity of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    A phase I study of trastuzumab-MCC-DM1 (T-DM1), a first-in-class HER2 antibody-drug conjugate (ADC), in patients (pts) with HER2+ metastatic breast cancer (BC) by Beeram, M., Krop, I., Modi, S., Tolcher, A., Rabbee, N., Girish, S., Tibbitts, J., Holden, S., Lutzker, S., Burris, H.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 1042 Background: ADCs utilize tumor-specific and/or over-expressed surface antigens that undergo internalization to deliver highly potent…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Fantastic reality by Tibbitts, S J

    Published in AORN journal (01-07-1970)
    Get more information
    Journal Article